DDT COA #000027: A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF)
Clinical Outcome Assessments (COA) Qualification Submissions
Office of Immunology and Inflammation (OII)
Division of Pulmonary, Allergy, and Critical Care (DPACC)
DDT COA Number
DDT COA #000027
Instrument Name
A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF)
Disease/Condition
Idiopathic pulmonary fibrosis (IPF)
Concept of Interest
Symptom experience, daily functioning and other health-related quality of life impacts
Context of Use
Adult patients (>18 years) with IPF
COA Type
PRO
Qualification Stage
Letter of Intent-Accepted
Requestor(s)
National Jewish Health
Contact(s)
Chris Evans
Date Accepted into CDER’s COA Qualification Program
January 25, 2012
Submission and Regulatory Correspondence History
|
Qualification Submission |
Date |
FDA Submission Decision & Recommendations |
Date |
|---|---|---|---|
|
-- |
-- |
9/5/19 |